Emil Kuriakose, MD
Chief Medical Officer, Oncology at Terns Pharmaceuticals- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
Topline Score
Bio
Experience
-
Terns Pharmaceuticals
-
United States
-
Pharmaceutical Manufacturing
-
1 - 100 Employee
-
Chief Medical Officer, Oncology
-
Mar 2023 - Present
Foster City, California, United States
-
-
-
Calithera Biosciences
-
United States
-
Pharmaceutical Manufacturing
-
1 - 100 Employee
-
Chief Medical Officer
-
Nov 2021 - Mar 2023
-
-
Vice President, Head of Clinical Development
-
Jan 2021 - Nov 2021
-
-
Vice President, Clinical Development
-
Feb 2020 - Nov 2021
South San Francisco, California
-
-
Senior Medical Director
-
Oct 2017 - Feb 2020
San Francisco Bay Area
-
-
-
Novartis
-
Switzerland
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
Global Clinical Program Lead
-
Jan 2016 - Sep 2017
East Hanover, NJ -Global head of early development for MDM2 inhibitor (targeted therapy) and adenosine inhibitor (I-O) programs in solid and hematologic malignancies -Responsible for creating and executing clinical development of new oncology agents from the candidate selection process (CSP) to clinical proof of concept (PoC) stage, encompassing strategy for path to registration -Responsible for integrated development plan including design and execution of phase 1 and 2 clinical trials of novel compounds… Show more -Global head of early development for MDM2 inhibitor (targeted therapy) and adenosine inhibitor (I-O) programs in solid and hematologic malignancies -Responsible for creating and executing clinical development of new oncology agents from the candidate selection process (CSP) to clinical proof of concept (PoC) stage, encompassing strategy for path to registration -Responsible for integrated development plan including design and execution of phase 1 and 2 clinical trials of novel compounds in oncology and immuno-oncology portfolio -Lead multi-disciplinary team comprised of clinical pharmacology, pre-clinical biology, pre-clinical safety, correlative biomarkers, technical research and development, biostatistics and data management, global clinical operations, global regulatory affairs, and early commercial strategy -Ensure ethical and efficient conduct of early phase clinical trials in compliance with Good Clinical Practice guidelines Show less
-
-
-
Novartis Oncology
-
Switzerland
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
Medical Director
-
Jul 2013 - Jan 2016
United States, East Hanover, NJ -Oversaw clinical development, strategy, and medical affairs program for Farydak (HDACi), Sonidegib (Hh inhibitor), and Afuresertib (AKTi) in the US. -Led cross-functional medical product teams consisting of clinical operations, field medical, managed markets, HEOR, drug regulatory, medical information, and scientific communications. -Developed LCM plan and strategy for compounds by disease state, working with key internal stakeholders. -Designed and executed phase 1 through 4 clinical… Show more -Oversaw clinical development, strategy, and medical affairs program for Farydak (HDACi), Sonidegib (Hh inhibitor), and Afuresertib (AKTi) in the US. -Led cross-functional medical product teams consisting of clinical operations, field medical, managed markets, HEOR, drug regulatory, medical information, and scientific communications. -Developed LCM plan and strategy for compounds by disease state, working with key internal stakeholders. -Designed and executed phase 1 through 4 clinical trials aligned with compound LCM strategy. -Oversaw over 75 medical affairs studies conducted in collaboration with third-party investigators. Show less
-
-
-
Memorial Sloan Kettering Cancer Center
-
United States
-
Hospitals and Health Care
-
700 & Above Employee
-
Research Fellow
-
Jun 2011 - Jun 2013
Research fellow in The Malcolm Moore Lab
-
-
-
Weill Cornell Medicine
-
United States
-
Hospitals and Health Care
-
700 & Above Employee
-
Hematology/Oncology Fellow
-
Jul 2010 - Jun 2013
Weill Cornell Medical College -Awarded The Johns Family Foundation Clinical Fellowship in hematology/oncology, -specialized in clinical and translational research in myeloproliferative neoplasms.
-
-
-
-
Attending Hospitalist
-
Jun 2009 - Jun 2010
-
-
-
UT Southwestern Medical Center
-
United States
-
Hospitals and Health Care
-
700 & Above Employee
-
Resident physician
-
Jul 2006 - Jun 2009
-
-
Education
-
New York University
BS, Neural Science -
SUNY Stony Brook Medical Center
Doctor of Medicine (MD)